Aromatic L‐amino acid decarboxylase deficiency in 17 Mainland China patients: Clinical phenotype, molecular spectrum, and therapy overview

Aromatic L‐amino acid decarboxylase deficiency (AADCD) is a rare, autosomal recessive inherited disorder which is characterized by neurological and vegetative symptoms. To date, only 130 patients with AADCD have been reported worldwide.

[1]  Consensus Guideline , 2020, Encyclopedia of Behavioral Medicine.

[2]  N. Blau,et al.  Aromatic amino acid decarboxylase deficiency: Molecular and metabolic basis and therapeutic outlook. , 2019, Molecular genetics and metabolism.

[3]  F. Fang,et al.  A novel DDC gene deletion mutation in two Chinese mainland siblings with aromatic l-amino acid decarboxylase deficiency , 2019, Brain and Development.

[4]  Takeshi Nakajima,et al.  Gene therapy improves motor and mental function of aromatic l-amino acid decarboxylase deficiency , 2019, Brain : a journal of neurology.

[5]  A. Paiardini,et al.  Heterozygosis in aromatic amino acid decarboxylase deficiency: Evidence for a positive interallelic complementation between R347Q and R358H mutations , 2018, IUBMB life.

[6]  Y. Chien,et al.  Natural History of Aromatic L-Amino Acid Decarboxylase Deficiency in Taiwan. , 2018, JIMD reports.

[7]  S. Peng,et al.  Microstructural changes of brain in patients with aromatic L‐amino acid decarboxylase deficiency , 2017, Human brain mapping.

[8]  M. Verbeek,et al.  Consensus guideline for the diagnosis and treatment of aromatic l-amino acid decarboxylase (AADC) deficiency , 2017, Orphanet Journal of Rare Diseases.

[9]  Jie Zhu,et al.  [Feeding difficulty and developmental delay for 8 months and nystagmus for 4 months in an infant]. , 2017, Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics.

[10]  N. Matsumoto,et al.  A female case of aromatic l-amino acid decarboxylase deficiency responsive to MAO-B inhibition , 2016, Brain and Development.

[11]  A. Giorgetti,et al.  A comprehensive picture of the mutations associated with aromatic amino acid decarboxylase deficiency: from molecular mechanisms to therapy implications. , 2014, Human molecular genetics.

[12]  P. Pearl,et al.  Widening Phenotypic Spectrum of AADC Deficiency, a Disorder of Dopamine and Serotonin Synthesis. , 2014, JIMD reports.

[13]  R. Richardson,et al.  Gene therapy for aromatic L-amino acid decarboxylase deficiency. , 2012, Neurosurgery.

[14]  A. Munnich,et al.  Kinetic analyses guide the therapeutic decision in a novel form of moderate aromatic Acid decarboxylase deficiency. , 2012, JIMD reports.

[15]  C. Manegold,et al.  Clinical and biochemical features of aromatic L-amino acid decarboxylase deficiency , 2010, Neurology.

[16]  S. Heales,et al.  A new perspective on the treatment of aromatic L-amino acid decarboxylase deficiency. , 2009, Molecular genetics and metabolism.

[17]  Hsiu-Fen Lee,et al.  Aromatic L-amino acid decarboxylase deficiency in Taiwan. , 2009, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[18]  C. Manegold,et al.  Aromatic l-amino acid decarboxylase deficiency: clinical features, drug therapy and follow-up , 2009, Journal of Inherited Metabolic Disease.

[19]  T. Nakayama,et al.  Aromatic l‐amino acid decarboxylase deficiency associated with epilepsy mimicking non‐epileptic involuntary movements , 2008, Developmental medicine and child neurology.

[20]  D. Goh,et al.  Unusually mild phenotype of AADC deficiency in 2 siblings. , 2007, Molecular genetics and metabolism.

[21]  C. Chiriboga,et al.  Aromatic l-amino acid decarboxylase deficiency , 2004, Neurology.

[22]  J. Marsh,et al.  Levodopa‐responsive aromatic L–amino acid decarboxylase deficiency , 2004, Annals of neurology.

[23]  V. Malashkevich,et al.  Structural insight into Parkinson's disease treatment from drug-inhibited DOPA decarboxylase , 2001, Nature Structural Biology.